Boothbay Fund Management LLC Takes $3.52 Million Position in M3-Brigade Acquisition V Corp. $MBAV

Boothbay Fund Management LLC bought a new position in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) in the third quarter, according to its most recent filing with the SEC. The firm bought 333,559 shares of the company’s stock, valued at approximately $3,519,000. Boothbay Fund Management LLC owned approximately 0.93% of M3-Brigade Acquisition V as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Sandia Investment Management LP purchased a new position in shares of M3-Brigade Acquisition V in the second quarter worth $334,000. Clear Street LLC lifted its stake in shares of M3-Brigade Acquisition V by 2,280.8% during the second quarter. Clear Street LLC now owns 32,069 shares of the company’s stock worth $362,000 after buying an additional 30,722 shares during the period. Radcliffe Capital Management L.P. purchased a new stake in shares of M3-Brigade Acquisition V during the third quarter valued at $544,000. Bluefin Capital Management LLC purchased a new stake in shares of M3-Brigade Acquisition V during the second quarter valued at $690,000. Finally, JPMorgan Chase & Co. acquired a new position in shares of M3-Brigade Acquisition V in the 2nd quarter valued at $900,000.

M3-Brigade Acquisition V Stock Down 0.7%

Shares of MBAV opened at $10.67 on Tuesday. The business’s 50-day moving average is $10.67 and its two-hundred day moving average is $10.63. M3-Brigade Acquisition V Corp. has a fifty-two week low of $10.19 and a fifty-two week high of $13.73.

Insider Buying and Selling

In related news, major shareholder Fitzgerald & Co. Cantor purchased 3,529,081 shares of M3-Brigade Acquisition V stock in a transaction that occurred on Wednesday, December 17th. The stock was bought at an average cost of $10.80 per share, for a total transaction of $38,114,074.80. Following the completion of the transaction, the insider owned 7,779,865 shares in the company, valued at $84,022,542. The trade was a 83.02% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.

Analysts Set New Price Targets

A number of brokerages have commented on MBAV. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research report on Monday, December 22nd. Wall Street Zen upgraded M3-Brigade Acquisition V to a “sell” rating in a research note on Saturday. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

About M3-Brigade Acquisition V

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.